Try our Advanced Search for more refined results

Viatris Nixes Biogen's Extra 1-Year Protection Over MS Drug

By Hanna Vioque ( September 24, 2025, 6:17 PM BST) -- A court agreed on Wednesday to cancel a European Commission decision that extended Biogen's market protection for the multiple sclerosis drug tecfidera for an extra year, allowing Viatris to enter the generics market months earlier....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies